| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
20/20 Biolabs, Inc.
13G
AIDX · 90138K101
|
6.3% |
3/10/2026
Event 2/19/2026
|
||||
| Full Succeed International Limited | 6.3% | |||||
| Nengyuan Pan | 6.3% | |||||
| Wei Lu | 6.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.